JACOBS LEVY EQUITY MANAGEMENT, INC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 195 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$12,254,000
-16.2%
704,024
-19.0%
0.13%
-19.6%
Q2 2020$14,623,000
+146.9%
869,400
+74.5%
0.16%
+107.9%
Q1 2020$5,923,000
+564.8%
498,130
+910.2%
0.08%
+375.0%
Q4 2017$891,000
+133.2%
49,310
+148.9%
0.02%
+128.6%
Q3 2017$382,000
+526.2%
19,810
+22.3%
0.01%
+600.0%
Q3 2015$61,00016,2000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders